Stay updated on TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.

Latest updates to the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag updated to v3.4.2. The previous Revision: v3.4.1 tag has been removed.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page shows a minor metadata update from Revision: v3.4.0 to v3.4.1, with no changes to study content or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a glossary toggle and footer metadata including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, indicating a minor deployment or patch; no changes to study data, content, or user-facing functionality are evident in the provided context, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedA new line noting the last known status and associated personnel was added to the study record. This change does not affect trial details or user actions.SummaryDifference0.4%

- Check63 days agoChange DetectedFooter now shows Revision: v3.3.3; the previous Revision: v3.3.2 and the HHS Vulnerability Disclosure link have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.